S&P; Will Add Chiron to 500 Index
- Share via
Monday was a down day for biotech shares, but Standard & Poor’s Corp. paid Chiron Corp. (CHIR) a compliment after trading ended: S&P; said it will add Chiron to the blue-chip S&P; 500 index.
Chiron, formerly a member of the S&P; mid-cap 400 index, will replace Fort James (FJ) in the S&P; 500 after the close of trading on a date to be announced, S&P; said. Fort James is being acquired.
Chiron is a biotechnology company that participates in three global health-care markets: biopharmaceuticals, blood testing and vaccines. The company is headquartered in Emeryville, Calif.
Chiron shares fell 13 cents to $38.13 before the announcement.
Inside the business of entertainment
The Wide Shot brings you news, analysis and insights on everything from streaming wars to production — and what it all means for the future.
You may occasionally receive promotional content from the Los Angeles Times.
